Introduction: Hyperparathyroidism is presented with increased parathyroid hormone (PTH) secretion due to hyperfunctioning of one or more of the four parathyroid glands. Primary hyperparathyroidism (p-HPT) can be due to parathyroid adenoma, hyperplasia or carcinoma of the parathyroid gland. Secondary hyperparathyroidism (s-HPT) is usually a response to hypocalcaemia and consecutive hyperplasia of the glands. Our aim was to compare the efficacy of 99m Tcmethoxyisobutylisonitrile (MIBI) SPECT/CT in identification of the location of the lesion(s) in cases of HPT by comparing these results with the findings of ultrasound (US) and planar scintigraphy. Methods: Forty one consecutive patients (54±17 age, 12 males and 29 females) with primary or secondary hyperparathyroidism were included. All patients were examined by US and afterwards patients underwent conventional double-phase 99m Tc-MIBI scintigraphy combined with neck SPECT/CT procedure. Planar images (early and delayed), US and SPECT/CT image sets were evaluated for adenoma localization at the neck and thorax. Regions of interest (ROIs), equal sized, were selected and compared, over the hyperfunctioning parathyroid tissue (accumulated impulses-counts value) and over the contralateral lobe of the thyroid gland (control counts value). Results: The ultrasonography detected 24 positive findings. The late phase of planar scan detected 26 positive findings. SPECT/CT presented with bigger detection rate than late planar phase or US (75.6%, 63.4%, 61.5%) and with higher sensitivity (100%, 83.8%, 77.4%), respectively. Conclusion: The SPECT/CT study seems reliable, sensitive and with added value in diagnosing hyperparathyroidism as a complementary method to planar scintigraphy. US as compatible method, should be performed prior the scintigraphy protocols.
INTRODUCTION
Hyperparathyroidism is presented with increased parathyroid hormone (PTH) secretion in the bloodstream, due to hyperfunctioning of one or more of the four parathyroid glands. PTH helps maintain an appropriate balance of calcium in the bloodstream and in tissues that depend on calcium for proper functioning. Primary hyperparathyroidism (p-HPT) is usually caused by a single hyperfunctioning parathyroid gland -(parathyroid adenoma in 85-96% of cases) or less frequently (10%-15%) is due to hyperplasia, multiple adenomas, and ~1% due to carcinoma [1, 2] . It may be asymptomatic [3] (75%-80% of cases) or symptomatic (20%-25% of cases). Secondary hyperparathyroidism (s-HPT) refers to the excessive secretion of PTH by the parathyroid glands in response to hypocalcaemia and associated hyperplasia of the glands. This disorder is especially seen in patients with chronic kidney failure. Failing kidneys do not convert enough vitamin D to its active form, and they do not adequately excrete phosphate. When this happens, insoluble calcium phosphate forms in the body and removes calcium from the circulation. Secondary hyperparathyroidism can also result from malabsorption (chronic pancreatitis, small bowel disease, and malabsorption-dependent bariatric surgery) in that the fat-soluble vitamin D cannot get reabsorbed. The practical choice for localization analysis in p-HPT and s-HPT is a combination of Tc-methoxyisobutylisonitrile (MIBI) scintigraphy and ultrasonography (US) [4] . The standard of care of HPT is a surgical excision of the responsible lesion(s) and the most effective combination of different modalities for planning operative strategy is very important. Our aim was to investigate the efficacy of 99m Tc-MIBI SPECT/CT study to identify the location of the lesion(s) in cases of HPT, by comparing it with US and dual phase 99m Tc-MIBI planar scan.
METHODS
Between December 2016 and June 2017, 41 consecutive patients (54±17 age, 12 males and 29 females) with diagnosis of p-HPT (30 patients, 73.17%) or s-HPT (11 patients, 26.83%) were admitted at the Institute of Pathophysiology and Nuclear Medicine for a parathyroid scintigraphy. The average PTH value in the p-HPT group was 1453±576 pg/ml, with average ionized Ca 2+ level=1.33±0.07 mmol/l. The average PTH value in the s-HPT group was 228±34 pg/ml, with average ionized Ca 2+ level = 1.27±0.05 mmol/l. This study was approved by the Ethical Committee of Medical faculty in Skopje, and consent has been obtained from each patient or subject after full explanation of the purpose and nature of all procedures used. Prior scintigraphy, we examined the patients by US of the neck region, separately, by two nuclear medicine specialists, both with over 5 years of experience in the field of expertise. For the US we used Phillips H.D 6, Version 1.1, probe 7,5Hz. After the US examination, all patients underwent conventional planar 99m Tc-MIBI double-phase scintigraphy combined with neck SPECT/CT study. Planar scintigraphy was performed after IV injection of 740MBq 99m Tc-MIBI and consisted of an early phase (10 minutes after injection) and delayed phase (2 hours after injection of the radiotracer). We used dual-headed gamma camera MEDISO DHV Nucline Spirit, with the 140 keV photo-peak using a lowenergy, high resolution (LEHR) parallel collimator, in AP, DL, LL projections. After the delayed phase, SPECT/CT study was performed using the Optima NM/CT 640 GE Health care dual detector/4-slice CT gamma camera, LEHR collimator, 120 views, and matrix size 128x128. The images were reconstructed with slice thickness 2.5 mm, slice spacing 2,5 mm and matrix size 512x512. Planar images (early and delayed), ultrasonography and SPECT/CT image sets were evaluated for adenoma localization at the neck and thorax. The results were interpreted by two nuclear medicine specialists, separately, as a blinded method of analysis. Afterwards, the interpretations were compared, and a match in the interpretations was considered as a positive scintigraphy finding. All patients with positive scintigraphy findings underwent surgical intervention. Postoperatively, a comparison analysis was performed between the positive scintigraphy findings and the positive histology findings, the latter being considered as the gold standard for a positive study. Blood levels of PTHintraoperative quick assay and postoperative evaluation (significant decrease in the concentration) and clinical and biochemical follow up of patients, also contributed to confirmation of the positive study and the success of the surgical procedure. Regions of interest (ROIs) were selected over the hyperfunctioning parathyroid tissue (accumulated impulses-counts value) and over the contralateral lobe of the thyroid gland (control counts value). The ROIs were equal sized.
Statistical analysis
Statistical analysis was performed with SPSS16 software (SPSS, Inc., Chicago, IL). Results are expressed as mean ± SD unless otherwise stated. The chi square statistic was used for comparison of categorical variables. Continuous variables were analyzed by Student's t-test. A probability level of random difference of p<0.05 was considered significant.
RESULTS
The ultrasonography revealed 24 positive findings versus (vs.) 15 negative, no data existed for 2 patients. The late phase of planar scan detected 26 positive findings for parathyroid adenoma and 15 negative (equal as the US), ( Tc-MIBI parathyroid scintigraphy has proven to be the single best imaging modality for preoperative localization of parathyroid adenomas. It was first reported in 1989 by Coakley and colleagues, with characteristic of superior image quality, more favorable dosimetry, and improved detection sensitivity than thallium [5, 6] . Neck ultrasonography is rapid, non-expensive, safe and non-invasive technique with sensitivity 65%-85% for detecting parathyroid adenomas [7] . In other studies sensitivity of ultrasonography (US) for detecting a single parathyroid adenoma was reported to be 56%-100% and specificity of 40%-99% in accurate localization of the lesions [8, 9]. However, parathyroid US is dependent on the experience of the operator and has a suboptimal detection rate for multinodular thyroid disease and silent areas, such as the mediastinum, trachea-esophageal groove, and retroesophageal region [10] . The distribution of 99m Tc-MIBI is proportional to the blood flow and mitochondrial activity; it is thought to be sequestered in the mitochondria once inside the cell [11] . In the early phase of the scintigraphy (10-15 minutes after application of the tracer) this tracer can be accumulated in both thyroid tissue and the parathyroid glands, but in the late phase (2-3 hours after) it usually washes out of normal thyroid tissue more rapidly than it does out of abnormal parathyroid tissue. This is the principle of the dual-phase method, which was first reported in 1992 [12] . High signal-tobackground ratio on the delayed images of Tc-MIBI from hyperfunctioning parathyroid than from the thyroid gland [13] . The utility on dual-phase methodology for parathyroid scintigraphy was reported by Taillefer et al. who demonstrated the diagnostic advantage of the differential washout [12] . The method had similar accuracy to the subtraction method, although few direct comparison studies have been reported [14, 15] . In our study, the early planar phase was positive in 20 patients and the delayed phase including SPECT/CT was positive in 31 patients. The results favor the delayed phase versus the early phase, and the analysis present significant advantage of the delayed phase findings (p<0.05). However, routinely we use the combination of the early and delayed phase, since it presents the best results in detecting hyperfunctional parathyroid tissue. Ultrasound in our study presented sensitivity of 77.4% and detection rate of 61.5 %, while planar scintigraphy presented sensitivity of 83.8% and detection rate of 63.4% with no statistically significant difference. The combination of Tc-MIBI scintigraphy for precise localization [16] . SPECT/CT affords the opportunity to shorten acquisition time, perform accurate attenuation correction, increase specificity, and improve localization of disease. However, the rate of persistent and recurrent disease after parathyroidectomy is high, ranging between 10% and 30% [17] . It is extremely important to correctly locate all parathyroid tissue preoperatively, because most failures occur when the surgeon does not remove all hyperfunctioning parathyroid tissue. CT, MRI, arteriography, and high resolution ultrasound have all been used in the diagnosis of secondary hyperparathyroidism. However, the performance of these anatomic techniques is not satisfactory in preoperative identification of hyperfunctional parathyroid tissue [18] . Tc-MIBI SPECT/CT could overcome the difficulty in pointing out the location of the lesion than planar image. As shown in the present series, intrathyroidal adenoma could not be identified by planar image, because of the lack in information of the depth of the lesion. SPECT/CT gave this information at a glance. Ultrasound, Tc-MIBI SPECT/CT determine the laterality of the lesion with accuracy of 84, 85 and 89% respectively, when applied in solitary [16] . SPECT/CT in our study presented sensitivity of 100% and detection rate of 75.6% and it presented significantly better diagnostic features when compared to US and planar scintigraphy alone (p<0.05). The goal of the study of Yang was to compare the diagnostic value of early and delayed phase of Tc-MIBI SPECT/CT together can depict more lesions than with either phase alone [19] . Higher sensitivity of early phase than delayed phase 99m Tc-MIBI SPECT scintigraphy was demonstrated by Carty et al. in the detection of parathyroid glands (sensitivity, 92% and 74%) [20] . However, Civelek et al. reported that delayed phase SPECT was a promising protocol in the preoperative detection and localization of parathyroid adenomas in both unexplored and reexplored patients. All patients had underwent both early and delayed phase scintigraphy, but CT data were acquired only once (used in both phases of 99m Tc-MIBI SPECT/CT, early and delayed).
SPECT -CT
This method does not entail more radiation dose than early or delayed phase scanning alone [21] . A major advantage of SPECT/CT seems to be its ability to differentiate inferior from inferior-posterior glands (superior glands in the trachea-esophageal groove). The statistical advantage of SPECT/CT was not evident when analysis was done with the inferior and inferior-posterior locations combined [22] . The factor most commonly reported to correlate with false-negative findings is the size of the parathyroid gland (i.e., smaller glands are less likely to be detected than larger glands [23, 24] , and inclusion of anatomic information may benefit patient treatment. SPECT/CT is particularly useful for equivocal cases or when uniglandular disease has been undetected with ultrasound techniques [25, 26] . Schachter et al. concluded that early phase SPECT is useful for localizing parathyroid adenomas and is superior to dual-phase delayed imaging. They reported that only 60% of adenomas exhibited retention of activity on delayed phase images. Therefore, delayed phase 99m Tc-MIBI may be non-diagnostic and is not recommended, if similar washout rates were found between thyroid and parathyroid tissue and thus cause false negative [27] . Neumann showed that the sensitivity (approximately 70%) for localizing an adenoma did not improve with SPECT/CT, but anatomic localization significantly improved the specificity (96% for SPECT/CT vs. 48% for SPECT alone, p < 0.006) [28] . Despite its high sensitivity and specificity, SPECT alone is substantially limited by low spatial resolution and its inability to provide anatomical detail. Dualmodality imaging systems which allow both functional and structural imaging to be performed during a single imaging session improve image quality in comparison to functional imaging only [29] . Fusion imaging resulting from hybrid devices has been reported to be clearly giving better localization of disease and differentiation between physiologic and pathologic uptake [30] .
CONCLUSION
The SPECT/CT protocol, according to our results, seems quite reliable and is a sensitive method in the diagnostic imaging algorithm of hyperparathyroidism. We suggest using SPECT/CT protocol as a complementary method to planar parathyroid scintigraphy whenever possible, selectively in p-HPT patients, but extensively in s-HPT patients. US as compatible method with scintigraphy, should be performed prior the scintigraphy protocols.
